Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 1786 AL 1800

Open window mapping with extended early meets late algorithm vs. conventional mapping for accessory pathway ablation

Sande JLM, Minguito-Carazo C, Melchor LG, Rodríguez-Mañero M, Seara JG, López XAF, García RB, Arias FG, Juanatey JRG.

J Interv Card Electrophysiol. 2025 Apr;68(3):643-653. doi: 10.1007/s10840-024-01943-3. Epub 2024 Dec 4.

Sex Differences in Parkinson's Disease: A Narrative Review

Cattaneo C, Pagonabarraga J.

Neurol Ther. 2025 Feb;14(1):57-70. doi: 10.1007/s40120-024-00687-6. Epub 2024 Dec 4.

Exercise your graft - An important lesson for cell replacement therapy for Parkinson's disease

Daadi MM, Snyder EY.

Exp Neurol. 2025 Mar;385:115085. doi: 10.1016/j.expneurol.2024.115085. Epub 2024 Dec 3.

Effects of levodopa/carbidopa intestinal gel infusion on autonomic symptoms in advanced Parkinson's disease: a systematic review

Galli S, De Carolis L, Bianchini E, Alborghetti M, Caliò B, Pacilio P, Fanciulli A, Pontieri FE, Rinaldi D.

Clin Auton Res. 2025 Apr;35(2):159-182. doi: 10.1007/s10286-024-01090-9. Epub 2024 Dec 4.

The Cycling Wheelchair as a New Mobility Aid for Individuals with Parkinson's Disease

Okada Y, Narita M, Okamoto M, Osumi M, Morioka S.

Mov Disord Clin Pract. 2025 Apr;12(4):545-546. doi: 10.1002/mdc3.14292. Epub 2024 Dec 5.

Examination of the autonomic nervous system at the bedside

Panigrahi B, Srivastava AK, Garg D, Jaryal A.

Acta Neurol Belg. 2025 Jun;125(3):625-634. doi: 10.1007/s13760-024-02654-2. Epub 2024 Dec 5.

Artificial intelligence for identification of candidates for device-aided therapy in Parkinson's disease: DELIST-PD study

Freire-Álvarez E, Ramírez IL, García-Ramos R, Carrillo F, Santos-García D, Gómez-Esteban JC, Martínez-Castrillo JC, Martínez-Torres I, Madrid-Navarro CJ, Pérez-Navarro MJ, Valero-García F, Vives-Pastor B, Muñoz-Delgado L, Tijero B, Martínez CM, Valls JM, Aler R, Galván IM, Escamilla-Sevilla F.

Comput Biol Med. 2025 Feb;185:109504. doi: 10.1016/j.compbiomed.2024.109504. Epub 2024 Dec 4.

Telemedicine in Alzheimer's disease and other dementias: Where we are?

Angelopoulou E, Papageorgiou SG.

J Alzheimers Dis. 2025 Jan;103(1):3-18. doi: 10.1177/13872877241298295. Epub 2024 Dec 5.

Interactions between antidiabetes medications and heart-brain axis

Ong LT, Sia CH.

Curr Opin Endocrinol Diabetes Obes. 2025 Feb 1;32(1):34-43. doi: 10.1097/MED.0000000000000896. Epub 2024 Dec 6.

The Comprehensive Anxiety and Parkinson's Scale (CAPS): co-development and initial validation of the long (CAPS-54) and short (CAPS-24) versions

Irving-Curran C, Deane KHO, Ford CEL, Bartholomew K, Malyon J, Chalmers R, Irving-Curran D.

Disabil Rehabil. 2025 Jul;47(15):3975-3981. doi: 10.1080/09638288.2024.2435522. Epub 2024 Dec 6.

Efficient Study Designs for the Early-Stage Evaluation of Disease-Modifying Treatments in Parkinson Disease

Ziegler A, Schmid M.

Neurology. 2025 Jan 14;104(1):e210218. doi: 10.1212/WNL.0000000000210218. Epub 2024 Dec 6.

GLP-1 receptor agonists for Parkinson's disease: An updated meta-analysis

Albuquerque MB, Nunes LEDB, Oliveira Maldonado JV, Melo Ferreira DG, Margato MM, Rabelo LV, Valença MM, Oliveira Cordeiro LH.

Parkinsonism Relat Disord. 2025 Jan;130:107220. doi: 10.1016/j.parkreldis.2024.107220. Epub 2024 Nov 29.

Glutathione S-transferase: A keystone in Parkinson's disease pathogenesis and therapy

Padhan P, Simran, Kumar N, Verma S.

Mol Cell Neurosci. 2025 Mar;132:103981. doi: 10.1016/j.mcn.2024.103981. Epub 2024 Dec 5.

Letter to the editor: The impact of anti-inflammatory therapy on Parkinson's disease incidence: A retrospective cohort study

Huang M.

Parkinsonism Relat Disord. 2025 Apr;133:107224. doi: 10.1016/j.parkreldis.2024.107224. Epub 2024 Dec 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias